CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 31 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01191242
NCT01191242N/ACompleted

Methadone Monitoring for Insights Into Adverse Events

Intermountain Health Care, Inc.·observational·Posted Aug 30, 2010·Updated Mar 29, 2017

In Brief

An observational study for Pain and Opiate Addiction. Completed, enrolled 31 participants across 2 sites.

Detailed Summary

Methadone has been an effective and inexpensive therapy in the management of chronic pain and opioid dependence. However it has been associated with sudden, unexpected deaths. Two mechanisms have been suggested, increased drug concentration in the blood, and a change in the heart rhythm. This study will look at blood samples for drug levels and genetic components and EKG's (a noninvasive test which reveals heart rhythm). There will be no intervention.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedAug 30, 2010
Enrollment StartAug 1, 2010
Primary CompletionMar 1, 2011
Study CompletionMay 1, 2011
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 15.8 years ago